Advertisement

Topics

Hong Kong market could open cash flood gates for U.S. biotechs

06:31 EDT 14 Jun 2018 | Reuters

(Reuters) - When U.S. biotech startup Sorrento Therapeutics named ex-Lehman Brothers executive Jiong Shao as its new finance chief about two months ago, it was widely seen as a move driven by his background in raising capital for Alibaba and Tencent....

Original Article: Hong Kong market could open cash flood gates for U.S. biotechs

NEXT ARTICLE

More From BioPortfolio on "Hong Kong market could open cash flood gates for U.S. biotechs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...